Your browser doesn't support javascript.
loading
Gambling disorder seeking treatment patients and tobacco use in relation to clinical profiles.
Jiménez-Murcia, Susana; Giménez, Mónica; Granero, Roser; Masuet-Aumatell, Cristina; Ramón, Josep M; Agüero, Fernando; Morchón, Sergio; Moragas, Laura; Baenas, Isabel; Del Pino-Gutierrez, Amparo; Codina, Ester; Valenciano-Mendoza, Eduardo; Mora-Maltas, Bernat; Valero-Solís, Susana; Etxandi, Mikel; Guillen-Guzmán, Elías; Menchón, José M; Fernández-Aranda, Fernando.
Afiliação
  • Jiménez-Murcia S; CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III. Madrid, Spain; Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, Barcelona, Spain; Department of Clinical Sciences, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain
  • Giménez M; Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, Barcelona, Spain; CIBER Salud Mental (CIBERSam), Instituto de Salud Carlos III. Madrid, Spain. Electronic address: monicauab@hotmail.com.
  • Granero R; CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III. Madrid, Spain; Department of Psychobiology and Methodology, Autonomous University of Barcelona, Barcelona, Spain. Electronic address: Roser.Granero@uab.cat.
  • Masuet-Aumatell C; Department of Clinical Sciences, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain; Department of Preventive Medicine, University Hospital of Bellvitge-IDIBELL, Barcelona, Spain. Electronic address: cmasuet@bellvitgehospital.cat.
  • Ramón JM; Department of Clinical Sciences, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain; Department of Preventive Medicine, University Hospital of Bellvitge-IDIBELL, Barcelona, Spain. Electronic address: jmramon@bellvitgehospital.cat.
  • Agüero F; Department of Clinical Sciences, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain; Department of Preventive Medicine, University Hospital of Bellvitge-IDIBELL, Barcelona, Spain. Electronic address: faguero@bellvitgehospital.cat.
  • Morchón S; Department of Preventive Medicine, University Hospital of Bellvitge-IDIBELL, Barcelona, Spain. Electronic address: smorchon@bellvitgehospital.cat.
  • Moragas L; Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, Barcelona, Spain. Electronic address: lmoragas@bellvitgehospital.cat.
  • Baenas I; CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III. Madrid, Spain; Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, Barcelona, Spain. Electronic address: ibaenas@bellvitgehospital.cat.
  • Del Pino-Gutierrez A; CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III. Madrid, Spain; Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, Barcelona, Spain; Department of Public Health, Mental Health and Perinatal Nursing, School of Nursing, University of Barcelona, Barc
  • Codina E; Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, Barcelona, Spain. Electronic address: ecodina@bellvitgehospital.cat.
  • Valenciano-Mendoza E; Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, Barcelona, Spain. Electronic address: edevalenciano@idibell.cat.
  • Mora-Maltas B; Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, Barcelona, Spain. Electronic address: bmora@idibell.cat.
  • Valero-Solís S; Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, Barcelona, Spain. Electronic address: svs172@hotmail.com.
  • Etxandi M; Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, Barcelona, Spain. Electronic address: metxandi@bellvitgehospital.cat.
  • Guillen-Guzmán E; Department of Child and Adolescent Psychiatry and Psychology, Institute of Neurosciences, Hospital Clinic Barcelona, Spain. Electronic address: eguillem@clinic.cat.
  • Menchón JM; Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, Barcelona, Spain; Department of Clinical Sciences, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain; CIBER Salud Mental (CIBERSam), Instituto de Salud Carlos III. Madrid, Spain. Electronic address: j
  • Fernández-Aranda F; CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III. Madrid, Spain; Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, Barcelona, Spain; Department of Clinical Sciences, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain
Addict Behav ; 114: 106723, 2021 03.
Article em En | MEDLINE | ID: mdl-33203595
ABSTRACT

OBJECTIVES:

Tobacco smoking and gambling disorder (GD) often co-occur. However, few studies have assessed the extent to which cigarette smoking may serve to classify and/or better define GD behaviour profiles.

METHODS:

Among a large sample of n = 3,652 consecutive treatment-seeking patients with GD (91% men). Smokers were compared to non-smokers across different sociodemographic, clinical, psychopathological and personality variables. The effect sizes for the means and the proportion differences between the groups were estimated. An evaluation of the smoking changes over the last 15 years was also performed.

RESULTS:

From the total sample, 62.4% of gamblers reported tobacco use. A decreasing linear trend in tobacco use was observed within the studied period, women having a more irregular pattern. The use of tobacco was linked to the use of alcohol and other illegal drugs. Gamblers who smoke, as compared to those who don't, presented lower education levels, lower social position indexes and active employment. They were younger, with an earlier age of onset, shorter duration of the gambling behavior, higher GD severity, more psychological symptoms, higher scores in novelty seeking and lower scores in reward dependence, self-directedness and self-transcendence.

CONCLUSIONS:

Gamblers seeking treatment who smoke display particular social, clinical, psychological, temperamental and character features different from non-smoking gamblers, suggesting that the presence or absence of comorbid smoking condition in GD should always be considered when developing an optimal treatment, as gamblers who smoke might need treatment strategies different from non-smoking gamblers.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 8_ODS3_consumo_sustancias_psicoactivas Base de dados: MEDLINE Assunto principal: Jogo de Azar Limite: Female / Humans / Male Idioma: En Revista: Addict Behav Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 8_ODS3_consumo_sustancias_psicoactivas Base de dados: MEDLINE Assunto principal: Jogo de Azar Limite: Female / Humans / Male Idioma: En Revista: Addict Behav Ano de publicação: 2021 Tipo de documento: Article